Identification of the cellular receptor for anthrax toxin.

Article Details

Citation

Bradley KA, Mogridge J, Mourez M, Collier RJ, Young JA

Identification of the cellular receptor for anthrax toxin.

Nature. 2001 Nov 8;414(6860):225-9.

PubMed ID
11700562 [ View in PubMed
]
Abstract

The tripartite toxin secreted by Bacillus anthracis, the causative agent of anthrax, helps the bacterium evade the immune system and can kill the host during a systemic infection. Two components of the toxin enzymatically modify substrates within the cytosol of mammalian cells: oedema factor (OF) is an adenylate cyclase that impairs host defences through a variety of mechanisms including inhibiting phagocytosis; lethal factor (LF) is a zinc-dependent protease that cleaves mitogen-activated protein kinase kinase and causes lysis of macrophages. Protective antigen (PA), the third component, binds to a cellular receptor and mediates delivery of the enzymatic components to the cytosol. Here we describe the cloning of the human PA receptor using a genetic complementation approach. The receptor, termed ATR (anthrax toxin receptor), is a type I membrane protein with an extracellular von Willebrand factor A domain that binds directly to PA. In addition, a soluble version of this domain can protect cells from the action of the toxin.

DrugBank Data that Cites this Article

Polypeptides
NameUniProt ID
Anthrax toxin receptor 1Q9H6X2Details